Are vaccines against COVID-19 tailored to the most vulnerable people?
Vaccine
.
2021 Apr 22;39(17):2325-2327.
doi: 10.1016/j.vaccine.2021.03.066.
Epub 2021 Mar 22.
Authors
Raffaele Antonelli Incalzi
1
,
Caterina Trevisan
2
,
Susanna Del Signore
3
,
Stefano Volpato
4
,
Stefano Fumagalli
5
,
Fabio Monzani
6
,
Giuseppe Bellelli
7
,
Pietro Gareri
8
,
Enrico Mossello
5
,
Alba Malara
9
,
Alessandra Coin
10
,
Gianluca Zia
3
,
Anette Hylen Ranhoff
11
Affiliations
1
Unit of Geriatrics, Department of Medicine, Campus Bio-Medico University and Teaching Hospital, Rome, Italy.
2
Geriatrics Division, Department of Medicine (DIMED), University of Padua, Italy. Electronic address: caterina.trevisan.5@studenti.unipd.
3
Bluecompanion Ltd, London, UK.
4
Department of Medical Science, University of Ferrara, Ferrara, Italy.
5
Geriatric Intensive Care Unit, Department of Experimental and Clinical Medicine, University of Florence, Italy.
6
Geriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
7
School of Medicine and Surgery, University of Milano-Bicocca and Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy.
8
Center for Cognitive Disorders and Dementia - Catanzaro Lido, ASP Catanzaro, Italy.
9
Scientific Committee of National Association of Third Age Residences (ANASTE) Calabria, Lamezia Terme (Catanzaro), Italy.
10
Geriatrics Division, Department of Medicine (DIMED), University of Padua, Italy.
11
Department of Clinical Science, University of Bergen, Norway and Diakonhjemmet Hospital, Oslo, Norway.
PMID:
33810907
PMCID:
PMC7983447
DOI:
10.1016/j.vaccine.2021.03.066
No abstract available
Keywords:
COVID-19; Frailty; Older people; Vaccines.
MeSH terms
Aged
COVID-19 Vaccines
COVID-19*
Frail Elderly
Frailty*
Humans
SARS-CoV-2
Substances
COVID-19 Vaccines